Tenax Therapeutics (TENX) Current Deferred Revenue (2013 - 2015)
Tenax Therapeutics recorded quarterly Current Deferred Revenue of $129945.0 in Q1 2015, little changed quarter-over-quarter from $129945.0 in Q4 2014, and up 4.98% year-over-year from $123786.0 in Q1 2014.
Tenax Therapeutics' Current Deferred Revenue history runs 3 years deep, the most recent figure standing at $129945.0 for Q1 2015.
- In Q1 2015, Current Deferred Revenue rose 4.98% year-over-year to $129945.0; the TTM figure through Jan 2015 stood at $129945.0 (up 4.98% YoY), while the FY2014 annual figure was $124521.0, down 32.72% from the prior year.
- Current Deferred Revenue came in at $129945.0 for Q1 2015 at Tenax Therapeutics, roughly flat from $129945.0 in the prior quarter.
- In the past five years, Current Deferred Revenue ranged from a high of $185068.0 in Q2 2013 to a low of $50937.0 in Q3 2013.
- A 3-year average of $115804.0 and a median of $127233.0 in 2014 frame the typical range for Current Deferred Revenue.
- On a YoY basis, Current Deferred Revenue climbed as much as 155.11% in 2014 and fell as far as 32.72% in 2014.
- Tenax Therapeutics' Current Deferred Revenue stood at $52285.0 in 2013, then jumped by 148.53% to $129945.0 in 2014, then changed by 0.0% to $129945.0 in 2015.
- According to Business Quant data, Current Deferred Revenue over the past three periods registered $129945.0, $129945.0, and $129945.0 for Q1 2015, Q4 2014, and Q3 2014 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Tenax Therapeutics | 542.72 Mn | 542.72 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2015 | 129,945.00 |
| Oct 31, 2014 | 129,945.00 |
| Jul 31, 2014 | 129,945.00 |
| Apr 30, 2014 | 124,521.00 |
| Jan 31, 2014 | 123,786.00 |
| Oct 31, 2013 | 52,285.00 |
| Jul 31, 2013 | 50,937.00 |
| Apr 30, 2013 | 185,068.00 |